1st lung cancer vaccine trials launch, powered by COVID mRNA technology

2 months ago 4
ARTICLE AD BOX
The mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries.
Read Entire Article